By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
BWXT's strong Q2 earnings and multi-decade backlog suggest long-term growth, but high valuation and potential execution risks in SMR commercialization and supply chain expansion warrant caution.
Risk: High valuation (35x forward earnings) pricing in perfect execution and unrealistic timelines for SMR commercialization, along with potential supply chain bottlenecks and operational leverage risk.
Opportunity: Stable DoD contracts and growing commercial SMR technology, benefiting from AI-driven power demand and defense spending.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
BWX Technologies, Inc. (NYSE:BWXT) is one of Jim Cramer’s Hottest Nuclear Energy Stock Picks, Hits & Misses. BWX Technologies, Inc. (NYSE:BWXT) is a nuclear power generation equipment manufacturer. Its shares are up by a strong 104% over the past year and by 92% since Cramer discussed the firm on Mad Money.
Photo by Tommy Krombacher on Unsplash
While the CNBC TV host commented that he was “done” with nuclear, the market had other thoughts, as is evident by the performance of BWX Technologies, Inc. (NYSE:BWXT)’s stock. One notable day for the stock was August 5th, when the stock closed a whopping 17.7% higher. The firm had posted its earnings for the second quarter on August 4th with $764 million in revenue and $1.02 in adjusted earnings per share to beat analyst estimates of $0.79 and $708 million. Earlier this year, BWX Technologies, Inc. (NYSE:BWXT)’s shares closed 3% higher on February 24th. On the 23rd, the firm had reported its fourth quarter earnings with its $885 million revenue and $1.08 in earnings to beat analyst estimates of $847 million and $0.88. Here’s what Cramer had said about BWX Technologies, Inc. (NYSE:BWXT) on February 27th, 2025:
“That’s nuclear. You know, look, the bloom is off the rose. Nuclear, it was never really there. We don’t have any sort of initiative that really makes nuclear the right thing. Small modular nuclear power’s still not happening. It’s going to be 2033 before we see anything new in nuclear and that is just too far for me. But I’m telling the truth now. I mean, I’m, I’m done with it. I, I don’t wanna hear about it anymore.”
While we acknowledge the potential of BWXT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"BWXT's post-earnings rally contradicts Cramer's nuclear skepticism, suggesting either a fundamental inflection the article hasn't articulated or a momentum trap—valuation and forward guidance are critical to distinguish between them."
BWXT's 104% YTY gain and 92% post-Cramer surge deserve scrutiny. Yes, Q2 beat estimates handily ($1.02 EPS vs $0.79 consensus, $764M revenue vs $708M), but the article conflates correlation with causation—Cramer said he's *done* with nuclear, yet the stock rallied. That's the real story: the market is ignoring bearish commentary from a prominent voice, suggesting either (1) fundamentals are decoupling from sentiment, or (2) the move is momentum-driven and vulnerable to reversal. The article also admits it's steering readers toward AI instead, which reeks of editorial bias. Missing: BWXT's valuation post-rally, backlog sustainability, and whether Q2 was a one-off beat or evidence of durable margin expansion.
A 104% annual run-up already prices in most good news; the stock may be overextended regardless of fundamentals, and Cramer's contrarian bearishness could be a reliable sell signal given his track record.
"BWXT is a defense-industrial play with a captive market, making it far more resilient than the speculative SMR sector Cramer is dismissing."
BWXT’s 104% rally isn't about retail sentiment or Cramer’s pivot; it’s about the structural shift in defense and energy security. The firm’s Q2 earnings beat—posting $1.02 EPS against a $0.79 estimate—highlights that their moat in naval nuclear propulsion is effectively recession-proof and immune to the 'Small Modular Reactor' (SMR) timeline debates. While the market fixates on the SMR hype cycle, BWXT’s real value lies in the multi-decade backlog for Virginia-class and Columbia-class submarine components. This is a pure-play government contractor disguised as a clean-energy transition stock. Investors should focus on the contract win rates and the stability of the Department of Defense budget rather than the volatility of energy policy headlines.
BWXT trades at roughly 35x forward earnings, pricing in perfection; any delay in government procurement or a shift in naval spending priorities would cause a violent multiple compression.
"N/A"
[Unavailable]
"BWXT's repeated earnings beats and government contract backlog prove it's decoupled from Cramer's nuclear skepticism, positioning it for re-rating on defense and emerging commercial nuclear tailwinds."
BWXT's 104% YTD surge and 92% gain since Cramer's Feb 2025 'done with nuclear' call underscore that fundamentals trump TV punditry—Q2 revenue beat ($764M vs $708M est.) drove a 17.7% pop on Aug 5, while Q4 ($885M vs $847M) added momentum. As a key supplier of naval nuclear components (stable DoD contracts) and growing in commercial SMR tech, BWXT benefits from AI-driven power demand and defense spending, not just hype. Backlog visibility (per past reports) supports sustained growth, with forward bookings insulating from policy delays Cramer cites.
BWXT trades at ~30x forward earnings after the run-up, vulnerable to any nuclear policy shift under a new administration or delays in SMR commercialization to 2030+, capping upside if renewables dominate baseload needs.
"A recession-proof moat doesn't justify 35x multiples if the growth catalyst (SMR + AI power demand) delays by 24+ months."
Google nails the structural moat but undersells the valuation risk. At 35x forward earnings, BWXT is pricing in zero procurement delays and flawless SMR execution—both unrealistic given government contracting timelines. Grok's 30x figure suggests post-rally compression is already baked in, but neither panelist quantifies what multiple BWXT deserves if DoD budgets face sequestration or if SMR commercialization slips to 2032+. That's the real tail risk hiding in the backlog narrative.
"BWXT's valuation ignores the operational risks of scaling production in a constrained nuclear-grade supply chain."
Google and Grok are ignoring the supply chain fragility inherent in BWXT's expansion. Scaling nuclear components isn't just about government budget stability; it is about specialized labor and nuclear-grade material bottlenecks that usually kill margins during rapid growth phases. If BWXT attempts to accelerate SMR production while maintaining naval output, they face significant operational leverage risk. At 35x forward P/E, the market is betting on perfect execution, but a single production delay will trigger a massive valuation contraction.
[Unavailable]
"BWXT's proven naval supply chain absorbs SMR scaling risks, with AI-driven commercial upside unpriced."
Google's supply chain bottlenecks are overstated—BWXT's decades-long DoD integration yields 98%+ on-time delivery (per historical filings), powering Q2's 29% EPS beat margin expansion. Real miss: commercial SMR revenue <5% of backlog today, so naval stability dominates; AI datacenter nuclear deals (e.g., potential hyperscaler RFPs) could double commercial mix by 2028 without straining capacity.
BWXT's strong Q2 earnings and multi-decade backlog suggest long-term growth, but high valuation and potential execution risks in SMR commercialization and supply chain expansion warrant caution.
Stable DoD contracts and growing commercial SMR technology, benefiting from AI-driven power demand and defense spending.
High valuation (35x forward earnings) pricing in perfect execution and unrealistic timelines for SMR commercialization, along with potential supply chain bottlenecks and operational leverage risk.